PATENT CLAIM ANALYSIS

Application Number: 15919678
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["546", "112000"]

Abstract:
The invention provides a crystalline sulfate salt of 3-endo-(8-{2-[cyclohexylmethyl-((S)-2,3-dihydroxy-propionyl)amino]ethyl}-8-aza-bicyclo[3.2.1]oct-3-yl)benzamide or a solvate thereof. The invention also provides pharmaceutical compositions comprising such crystalline salt forms, methods of using such crystalline salt forms to treat diseases associated with mu opioid receptor activity, and processes useful for preparing such crystalline salt forms.

Claim (Index 10):
The method of  claim 8 , wherein the x-ray powder diffraction pattern comprises two or more diffraction peaks at 2\u03b8 values selected from 14.69\u00b10.20, 16.01\u00b10.20, 21.11\u00b10.20, 22.07\u00b10.20, and 23.18\u00b10.20.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 90.0
- Lexical Diversity: 1.43396
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13081162', '12072534', '13550781', '13965691', '14333003']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8730138846863916
- 35 USC 102 Novelty (BERT): 0.6844962179596433
- Combined Prediction Score: 0.8541621180137169
- Mean Citation Score: 693.9603860000003
- Max Citation Score: 700.8162
- Similarity Product: 684.6698566088677

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test